COMPANY
Cascade Biocatalysts Inc.
Funding and NIH signals
- NIH award NIH awarded $307K (SBIR Phase I 1R43TR006332-01, new, notice Aug 5, 2026). NIH RePORTER 1R43TR006332-01 (Aug 5, 2026)
Evidence (1 event)
- Aug 5, 2026 · NIH RePORTER 1R43TR006332-01
Organization: CASCADE BIOCATALYSTS INC.; City/State: DENVER, CO; Project number: 1R43TR006332-01; Activity code: R43; Fiscal year: 2026; Award notice date: 2026-08-05; FY total cost (award amount): 306871; Administering IC: National Center for Advancing Translational Sciences; Project title: Immobilized Cofactor Regeneration Systems to Accelerate Enzymatic API Manufacturing; Organization type: Domestic For-Profits
- Aug 5, 2026 · NIH RePORTER 1R43TR006332-01